Source link : https://www.newshealth.biz/health-news/fda-approves-pembrolizumab-for-stage-3-4a-cervical-cancer/
Pembrolizumab (Keytruda) has picked up yet another cancer indication, this time for stage 3-4a cervical cancer in combination with chemoradiation therapy. The new US Food and Drug Administration (FDA) approval marks the 40th oncology indication for the immunotherapy drug, spanning 19 cancer types, including two previous metastatic cervical cancer approvals. The new indication is based […]
Author : News Health
Publish date : 2024-01-16 14:52:56
Copyright for syndicated content belongs to the linked Source.